• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质量调整生命年(QALYs)的质量:QALYs是否衡量了它们至少想要衡量的东西?

The quality of QALYs (quality-adjusted-life-years): do QALYs measure what they at least intend to measure?

作者信息

Gafni A

出版信息

Health Policy. 1989 Oct;13(1):81-3. doi: 10.1016/0168-8510(89)90112-7.

DOI:10.1016/0168-8510(89)90112-7
PMID:10296157
Abstract

This note alerts the readers to the fact that QALYs (quality-adjusted-life-years) do not stem directly from the individual's utility function and thus, at best, only partly reflect an individual's true preferences. This might lead to the choice of the non-preferred alternative due to the misrepresentation of the individual's preference. This is illustrated by using a simple example from Mehrez and Gafni (1989).

摘要

本注释提醒读者注意,质量调整生命年(QALYs)并非直接源自个体的效用函数,因此,充其量仅能部分反映个体的真实偏好。这可能会因个体偏好的错误表述而导致选择非偏好的选项。梅雷兹和加夫尼(1989年)给出的一个简单例子说明了这一点。

相似文献

1
The quality of QALYs (quality-adjusted-life-years): do QALYs measure what they at least intend to measure?质量调整生命年(QALYs)的质量:QALYs是否衡量了它们至少想要衡量的东西?
Health Policy. 1989 Oct;13(1):81-3. doi: 10.1016/0168-8510(89)90112-7.
2
Quality-adjusted life years, utility theory, and healthy-years equivalents.质量调整生命年、效用理论与健康年当量。
Med Decis Making. 1989 Apr-Jun;9(2):142-9. doi: 10.1177/0272989X8900900209.
3
QALYs versus HYEs (healthy year equivalents): a reply to Gafni, Birch and Mehrez.质量调整生命年与健康等效年(HYEs):对加夫尼、伯奇和梅雷兹的回应。
J Health Econ. 1995 May;14(1):39-45. doi: 10.1016/0167-6296(94)00034-2.
4
The use of QALYS (quality-adjusted life years) in health service planning.质量调整生命年(QALYs)在卫生服务规划中的应用。
Int J Health Plann Manage. 1989 Oct-Dec;4(4):261-73. doi: 10.1002/hpm.4740040403.
5
Quality-adjusted life-years. Ethical implications for physicians and policymakers.质量调整生命年。对医生和政策制定者的伦理影响。
JAMA. 1990 Jun 6;263(21):2917-21. doi: 10.1001/jama.263.21.2917.
6
QALYs and HYEs (healthy year equivalents): under what conditions are they equivalent?质量调整生命年与健康等效年:在何种条件下它们是等效的?
J Health Econ. 1995 May;14(1):17-37. doi: 10.1016/0167-6296(94)00033-z.
7
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.
8
Economics, health and health economics: HYEs versus QALYs--a response.经济学、健康与健康经济学:卫生保健效果评估年与质量调整生命年——回应
J Health Econ. 1995 Aug;14(3):397-8. doi: 10.1016/0167-6296(95)00009-7.
9
Quality-adjusted life years: origins, measurements, applications, objections.
Aust J Public Health. 1993 Sep;17(3):272-8. doi: 10.1111/j.1753-6405.1993.tb00149.x.
10
Utilities and quality-adjusted life years.效用与质量调整生命年。
Int J Technol Assess Health Care. 1989;5(4):559-75. doi: 10.1017/s0266462300008461.

引用本文的文献

1
Cost-Utility Analysis of Antibiotic Therapy versus Appendicectomy for Acute Uncomplicated Appendicitis.抗生素治疗与阑尾切除术治疗急性单纯性阑尾炎的成本-效用分析。
Int J Environ Res Public Health. 2021 Aug 11;18(16):8473. doi: 10.3390/ijerph18168473.
2
Principlism and Personalism. Comparing Two Ethical Models Applied Clinically in Neonates Undergoing Extracorporeal Membrane Oxygenation Support.原则主义与个人主义。比较两种在接受体外膜肺氧合支持的新生儿临床应用中的伦理模式。
Front Pediatr. 2019 Jul 30;7:312. doi: 10.3389/fped.2019.00312. eCollection 2019.
3
Treatment Decisions for Babies with Trisomy 13 and 18.
13三体和18三体综合征患儿的治疗决策
HEC Forum. 2017 Sep;29(3):213-222. doi: 10.1007/s10730-017-9319-2.
4
Bridging decision analytic modelling with a cross-sectional study. Application to Parkinson's disease.
Pharmacoeconomics. 2000 Mar;17(3):227-36. doi: 10.2165/00019053-200017030-00001.
5
Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature.癌症治疗经济评估中的效益估值:已发表文献的系统综述
Pharmacoeconomics. 1999 Jul;16(1):17-31. doi: 10.2165/00019053-199916010-00003.
6
Assessing the benefits of health care: how far should we go?评估医疗保健的益处:我们应该走多远?
Qual Health Care. 1995 Sep;4(3):207-13. doi: 10.1136/qshc.4.3.207.
7
Principles of pharmacoeconomic analysis of drug therapy.药物治疗的药物经济学分析原则。
Pharmacoeconomics. 1992 Jan;1(1):20-31. doi: 10.2165/00019053-199201010-00006.
8
Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYEs).药物干预经济评估中基于偏好的结局指标:质量调整生命年(QALYs)与健康年当量(HYEs)。
Pharmacoeconomics. 1992 May;1(5):338-45. doi: 10.2165/00019053-199201050-00005.
9
Health policy approaches to measuring and valuing human life: conceptual and ethical issues.衡量和评估人类生命的卫生政策方法:概念和伦理问题。
Am J Public Health. 1995 Oct;85(10):1356-60. doi: 10.2105/ajph.85.10.1356.
10
Ionic versus nonionic contrast media: a burden or a bargain?离子型与非离子型造影剂:负担还是实惠?
CMAJ. 1990 Sep 15;143(6):475-8.